Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Monoclonal antibodies in gastrointestinal cancers.
Bronte G, Cicero G, Cusenza S, Galvano A, Musso E, Rizzo S, Sortino G, Roselli M, Bazan V, Fiorentino E, Russo A. Bronte G, et al. Among authors: musso e. Expert Opin Biol Ther. 2013 Jun;13(6):889-900. doi: 10.1517/14712598.2013.774367. Epub 2013 Feb 27. Expert Opin Biol Ther. 2013. PMID: 23441760 Free article. Review.
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy.
Bronte G, Bronte E, Novo G, Pernice G, Lo Vullo F, Musso E, Bronte F, Gulotta E, Rizzo S, Rolfo C, Silvestris N, Bazan V, Novo S, Russo A. Bronte G, et al. Among authors: musso e. Expert Opin Drug Saf. 2015 Feb;14(2):253-67. doi: 10.1517/14740338.2015.986092. Epub 2014 Dec 13. Expert Opin Drug Saf. 2015. PMID: 25494575 Review.
Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN.
Paz-Ares L, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Musso E, Havel L, Bondarenko I, Losonczy G, Conev N, Mann H, Dalvi TB, Jiang H, Goldman JW. Paz-Ares L, et al. Among authors: musso e. ESMO Open. 2022 Apr;7(2):100408. doi: 10.1016/j.esmoop.2022.100408. Epub 2022 Mar 10. ESMO Open. 2022. PMID: 35279527 Free PMC article. Clinical Trial.
The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE).
Quartuccio N, Ialuna S, Scalisi D, D'Amato F, Barcellona MR, Bavetta MG, Fusco G, Bronte E, Musso E, Bronte F, Picciotto V, Carroccio A, Verderame F, Malizia G, Cistaro A, La Gattuta F, Moreci AM. Quartuccio N, et al. Among authors: musso e. Curr Oncol. 2024 Mar 13;31(3):1504-1514. doi: 10.3390/curroncol31030114. Curr Oncol. 2024. PMID: 38534947 Free PMC article.
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development.
Caviglia GP, Abate ML, Troshina G, Carucci P, Rolle E, Risso A, Burlone ME, Albè A, Crevola M, Musso EC, Rosso C, Armandi A, Olivero A, Minisini R, Saracco GM, Bugianesi E, Pirisi M, Ciancio A, Gaia S. Caviglia GP, et al. Among authors: musso ec. Biology (Basel). 2023 Jan 7;12(1):94. doi: 10.3390/biology12010094. Biology (Basel). 2023. PMID: 36671786 Free PMC article.
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients.
Cosentini D, Badalamenti G, Grisanti S, Basile V, Rapa I, Cerri S, Spallanzani A, Perotti P, Musso E, Laganà M, Ferrari VD, Luppi G, Dalla Volta A, Incorvaia L, Sigala S, Russo A, Volante M, Terzolo M, Berruti A. Cosentini D, et al. Among authors: musso e. Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570. Eur J Endocrinol. 2019. PMID: 31639772
133 results